Key terms
About AVIR
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AVIR news
No recent press releases are available for AVIR
AVIR Financials
Key terms
Ad Feedback
AVIR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AVIR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range